TIGIT-targeted IL-12 fusion protein engages NK and CD8(+) T cells for potent tumor immunotherapy. (linkinghub.elsevier.com)

Authors: Tang M … Zheng X Journal: Cell Reports Medicine Published: 2026-06-16 DOI: https://doi.org/10.1016/j.xcrm.2026.102876